← Back to Search

Combined Exercise + Behavioural Counselling for Breast Cancer

N/A
Waitlist Available
Led By Linda Trinh, PhD
Research Sponsored by University of Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up post-intervention (8 weeks).
Awards & highlights

Study Summary

This trial will examine how exercise and counselling can help women with breast cancer manage anxiety/depression and improve cognitive function.

Eligible Conditions
  • Breast Cancer

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~post-intervention (8 weeks).
This trial's timeline: 3 weeks for screening, Varies for treatment, and post-intervention (8 weeks). for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence rate
Adverse events
Attrition rate
+2 more
Secondary outcome measures
Crystallized Cognition
Episodic Memory
Executive/Attention
+9 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Combined Exercise + Behavioural CounsellingExperimental Treatment1 Intervention
The combine exercise intervention will consist of three 30-minute, supervised, remotely-delivered resistance training classes as well as three 30-minute, unsupervised aerobic training (i.e., walking) items each week. Participants will also participate in bi-weekly, 30-40 minute, remotely-delivered behavioural counselling sessions delivered via videoconferencing (i.e., Zoom). The program will be taught by a Registered Kinesiologist via videoconferencing (i.e., Zoom). Participants will be asked to participate in the intervention for 8 weeks.
Group II: Active ControlActive Control1 Intervention
The active control group will participate in three 30-minute, supervised, remotely-delivered classes targeting balance and flexibility. The program will be delivered at a low-intensity by a Registered Kinesiologist via videoconferencing (i.e., Zoom). Participants will be asked to participate in the program for 8 weeks.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Combined Exercise + Behavioural Counselling
2023
N/A
~30

Find a Location

Who is running the clinical trial?

University of TorontoLead Sponsor
689 Previous Clinical Trials
1,018,622 Total Patients Enrolled
8 Trials studying Breast Cancer
3,251 Patients Enrolled for Breast Cancer
Linda Trinh, PhDPrincipal InvestigatorUniversity of Toronto
3 Previous Clinical Trials
165 Total Patients Enrolled
1 Trials studying Breast Cancer
18 Patients Enrolled for Breast Cancer

Media Library

Active Control Clinical Trial Eligibility Overview. Trial Name: NCT05704855 — N/A
Breast Cancer Research Study Groups: Combined Exercise + Behavioural Counselling, Active Control
Breast Cancer Clinical Trial 2023: Active Control Highlights & Side Effects. Trial Name: NCT05704855 — N/A
Active Control 2023 Treatment Timeline for Medical Study. Trial Name: NCT05704855 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial extend to those of underage status?

"The requirements for participant eligibility in this clinical trial state that individuals must be between 40 and 65 years of age."

Answered by AI

Am I eligible to take part in this clinical research?

"This medical trial is seeking 36 participants with breast cancer between the ages of 40 and 65."

Answered by AI

Are there any opportunities remaining for participants to join this investigation?

"Clinicaltrials.gov reports that this investigation is not currently enrolling subjects, despite its initial posting date of February 1st 2023 and latest update on January 19th 2023. Fortunately, there are 2,527 other active studies seeking volunteers at the moment."

Answered by AI

What are the primary objectives of this clinical research?

"The primary outcome of this research study will be evaluated over an 8 week period and measure the patient's adherence rate. Secondary outcomes involve assessing Episodic Memory, Language Capacity and Crystallized Cognition; all three are measured using different elements from NIH Toolbox Cognition Battery (Weintraub et al., 2013). The Picture Sequence Memory Test measures participants' ability to remember sequences of pictures with a duration of 10 minutes, while the Picture Vocabulary Test assesses individuals' vocabulary acquisition through 4 images paired with spoken words in 5 minutes or less. Lastly, Crystallized Cognition Composite is composed by averaging two normalized scores that evaluate"

Answered by AI
~10 spots leftby Apr 2025